Mergers and Acquisitions - Moore Threads plans to use no more than 7.5 billion yuan of idle raised funds for cash management [3] - Tian康 Bio intends to acquire 51% equity of Qiangdu Livestock for 1.275 billion yuan [3] - Greenmeadow plans to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [3] - Chongqing Water intends to acquire a sewage treatment project for 382 million yuan [3] - Enjie shares plans to acquire 100% equity of Zhongke Hualian, with stock resuming trading [3] - Rongbai Technology plans to acquire part of the equity of Guizhou Xinren and increase capital to achieve control [3] - Jiahuan Energy plans to merge with its wholly-owned subsidiary Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd. [3] Financing Activities - Guangzhou Development received a registration notice for 8 billion yuan medium-term notes and 6 billion yuan short-term financing bonds [3] - Poly Development plans to issue convertible bonds to raise no more than 5 billion yuan [3] - Liaoning Chengda's 3 billion yuan medium-term notes have been approved for registration [3] - Tianyu Bio's application for issuing A-shares to specific targets in 2025 has been accepted by the Shanghai Stock Exchange [3] - Tonglian Precision's application for issuing convertible bonds to unspecified targets has been approved by the Shanghai Stock Exchange [3] Shareholding Changes - Xice Testing's actual controller plans to transfer 5% of the company's shares through an agreement [3] - China High-Tech's control is set to change, with stock suspension starting December 15 [3] Buybacks and Shareholding Adjustments - Oppein Home's actual controller and concerted actors plan to increase their holdings of company shares by 50 million to 100 million yuan [3] - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [3] - Xilong Science's private equity intends to reduce its holdings by no more than 1% of the company's shares [3] - Jincheng shares' actual controller and concerted actors plan to reduce their holdings by no more than 0.97% [3] Operational Data - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [4] Major Investments - New Fengming plans to invest 280 million USD in a 360,000 tons/year functional fiber project in Egypt [5] - Tian Shun Wind Power plans to raise no more than 1.95 billion yuan for the expansion of the Changfeng New Energy Equipment Manufacturing Base [5] - Lei Sai Intelligent plans to raise no more than 1.144 billion yuan for core components of intelligent equipment motion control [5] - Hainan Development's subsidiary plans to invest 215 million yuan in the second phase of the Zhuhai production base [5]

Company Announcements - Moer Thread plans to use 7.5 billion yuan of idle raised funds for cash management, investing in safe and liquid principal-protected products [2] - Chipone Technology has terminated the acquisition of 97% equity in Chipwise [3] - Renfu Pharmaceutical's stock will be subject to risk warning and renamed ST Renfu due to false financial disclosures in its annual report [3] - Enjie Co., Ltd. intends to acquire 100% of Zhongke Hualian's shares, with stock resuming trading on December 15 [3] Investments & Contracts - Chipone Technology plans to jointly invest in TianSui Chip and acquire control of Zhudian Semiconductor [8] - Jiangsu Guoxin's subsidiary has officially put a 1 million kilowatt unit into operation [17] - Zhongyuan Shipping has signed contracts for the construction of 19 vessels, with a total value of 7.882 billion yuan [18] Financing & Capital Increase - Tiens Wind Power plans to raise no more than 1.95 billion yuan through a private placement for the expansion of its new energy equipment manufacturing base [18] - Chang'an Automobile's subsidiary, Chang'an Technology, plans to increase capital by 600 million yuan, aiming to hold a 75% stake post-increase [10] - Tiankang Biological intends to acquire 51% of Qiangdu Livestock for 1.275 billion yuan, enhancing its feed technology and animal health systems [11] Shareholder Changes - Xicai Testing's controlling shareholder plans to transfer 4.22 million shares at a price of 48.59 yuan per share [17] - Xicheng Science's shareholder plans to reduce holdings by no more than 1% [16] Other Developments - Huaying Technology has received a final judgment to be compensated 3.029 billion yuan, which is expected to positively impact its operations [5] - Fushik Holdings will pay up to 1.35 million yuan in economic compensation to departing employees [21]

信托行业的历练不仅塑造了其多元化的金融视角，更锤炼了其在大规模资本运作与长期投资管理上的能力。这种优势在其调任江苏高投后进一步显现—— 截至2025年9月底，江苏高投累计管理资本规模超3000亿元，牵头运作的500亿元江苏省战略性新兴产业母基金，以15年起步的"耐心资本"定位深耕硬科技 领域，这与信托业务长期限、稳回报的核心特质一脉相承。 江苏信托前总经理王会清拟出任华泰证券董事长！ 值得一提的是，华泰证券第一大股东江苏国信与江苏高投同属江苏国资体系，而王会清同时具备江苏信托、江苏国信、江苏高投等多家股东单位任职经 历，其跨平台资源整合能力与对股东战略的深刻理解，为华泰证券后续深化产融协同、拓展长期资本业务埋下伏笔。 江苏高科技投资集团（简称"江苏高投"）党委书记、董事长王会清已出任华泰证券新党委书记，经相关程序后，或将正式接替张伟担任华泰证券董事长， 此次人事调整已随江苏省委组织部的任职公示浮出水面，目前华泰证券暂未就此作出正面回应。 作为江苏国资体系培育的金融管理人才，王会清的职业履历中，近十年信托领域深耕经历尤为亮眼，成为其接掌头部券商的重要加分项。 公开资料显示，王会清于2009年从政府机关转型进入金 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Monetary Policy - As of the end of November, the broad money supply (M2) in China reached 336.99 trillion yuan, reflecting a year-on-year growth of 8% [1] - The narrow money supply (M1) stood at 112.89 trillion yuan, with a year-on-year increase of 4.9% [1] - The currency in circulation (M0) amounted to 13.74 trillion yuan, showing a year-on-year growth of 10.6% [1] - A net cash injection of 917.5 billion yuan occurred in the first eleven months of the year [1] Banking and Financial Services - The total scale of bank wealth management products has reached a historic high of approximately 33.8 trillion yuan, nearing 34 trillion yuan [2] - In the first eleven months, 14 wealth management companies collectively grew by about 3.43 trillion yuan, with "fixed income plus" products contributing an additional 1.32 trillion yuan [2] - The market saw a significant increase of 1.67 trillion yuan in the fourth quarter alone, accounting for nearly half of the annual growth [2] Regulatory Developments - The China Securities Investment Fund Industry Association has drafted a consultation document to standardize fund sales behavior, aiming to prevent misleading practices and protect investor rights [2] - The document outlines clear requirements for fund promotion, sales information disclosure, and performance assessment [2] Corporate Actions - Taihao Technology plans to use 13.67 billion yuan from its capital reserves to cover significant losses, a move that reflects a broader trend among A-share companies to address accumulated losses amid new regulatory changes [4] - Over 30 listed companies have announced similar plans to utilize capital reserves to offset losses, with total amounts exceeding 30 billion yuan [4] Market Trends - The top ten wafer foundries reported a quarter-on-quarter revenue increase of 8.1% in Q3 2025, driven by demand for AI and consumer electronics [4] - The global wafer foundry industry is expected to face challenges in 2026 due to international market conditions and conservative demand forecasts [4] Industry Developments - A new company, Beijing Guanghe Qiancheng Technology, has been established by leading silicon material firms, marking a significant step towards reducing overcapacity in the photovoltaic industry [5] - Future silicon material production capacity is planned to be capped at 1.5 million tons [5] Legal and Compliance Issues - The China Securities Regulatory Commission has penalized three individuals for manipulating the stock of Shandong Jincheng Pharmaceutical Group, resulting in fines and market bans [3] - Huayi Brothers' founder has received a consumption restriction order due to an advertising contract dispute, with the company facing a financial penalty of over 11.4 million yuan [8] IPO and Market Activity - Youyan Composite Materials has received approval for its IPO on the Sci-Tech Innovation Board [9] - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange [10] Corporate Changes - The chairman of Jinling Hotel has resigned due to work changes, leaving the company without any executive positions held by him [11] - *ST Chang Pharmaceutical's subsidiary has recently ceased operations due to financial difficulties and competitive pressures in the photovoltaic sector [12] Project Announcements - Jiangsu Guoxin's subsidiary has successfully completed the trial operation of a new 1000MW coal-fired power generation unit [13] - *ST Zhisheng has won a 1.04 billion yuan contract for a smart city governance project, significantly impacting its projected annual revenue [17]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

股票频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 格隆汇12月12日丨江苏国信(002608.SZ)公布，公司控股子公司江苏国信马洲发电有限公司（以下简 称"国信马洲"）新建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于 2025年12月12日正式投产运营。 此次投产的国信马洲100万千瓦机组选用先进的二次再热、超超临界技术，机组能源利用率高，各排放 指标实现超低排放；创新融合煤电机组熔盐储能系统，可高效灵活响应新型电力系统的调节需求。该机 组投产后将填补江苏省"十五五"期间电力供应缺口，进一步优化区域电力结构。 ...

江苏国信（002608）(002608.SZ)公告，公司控股子公司江苏国信马洲发电有限公司(简称"国信马洲")新 建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月12日正 式投产运营。 ...

智通财经APP讯，江苏国信(002608.SZ)公告，公司控股子公司江苏国信马洲发电有限公司(简称"国信马 洲")新建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月 12日正式投产运营。 ...

每经AI快讯，12月12日，江苏国信(002608.SZ)公告称，公司控股子公司江苏国信马洲发电有限公司新 建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月12日正 式投产运营。该机组能源利用率高，各排放指标实现超低排放，并创新融合煤电机组熔盐储能系统，可 高效灵活响应新型电力系统的调节需求。该机组投产后将填补江苏省"十五五"期间电力供应缺口，进一 步优化区域电力结构。 ...